Direct Distribution Would Increase Manufacturer Costs By 11.6% – Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmaceutical manufacturers would increase their costs by $10.5 bil. if they replace wholesalers with a direct distribution system, a report commissioned by the Healthcare Distribution Management Association states
You may also be interested in...
Wholesaler “Anti-Competitive” Practices Under Investigation By FTC
McKesson, Cardinal Health acknowledge ongoing FTC investigation in SEC filings, while AmerisourceBergen declines to comment. Inquiry aims to determine if distributors engaged in practices to limit competition, according to the filings.
Wholesaler “Anti-Competitive” Practices Under Investigation By FTC
McKesson, Cardinal Health acknowledge ongoing FTC investigation in SEC filings, while AmerisourceBergen declines to comment. Inquiry aims to determine if distributors engaged in practices to limit competition, according to the filings.
Cardinal Moves One Step Closer To Fee For Service With Third Manufacturer Contract
The wholesaler signed one more brand-name drug manufacturer to a fee-for-service distribution contract in November. McKesson is also moving to the new reimbursement model and believes it will complete most of its fee-for-service contracts by February.